2010留学生Npc

Embed Size (px)

DESCRIPTION

 

Citation preview

  • 1. Nasopharyngeal Carcinoma N P C Mai Hai-Qiang ( ) Department ofNPC Sun Yat-Sen University Cancer Center

2. WhatisNPC ? A very special type ofhead and neck cancer Different from other malignancies of the upperaerodigestive tract with regard to- Epidemiology, -Histology, -Clinical presentationsand -Treatment strategies. 3. N P C --- Canton Cancer

  • 80% of patients with NPCare found in
  • Southeast Asia, especially in southern
  • China : GuangDong Province

Why is it called Canton Cancer 4. Epidemiology

  • Evident geographic distribution difference
  • Specific susceptible population
  • Family cluster phenomenon
  • Stable Incidence Rate and Men to Women Ratio: 2 ~ 3.8:1
  • Differences between high and low incidence areas

5. Evident geographic distribution difference

  • Endemic areas:
  • Highest incidence:GuangDong province.
  • High incidences:Southern China
  • GuangXi;HuNan; FuJian; JiangXi and Hainan.
  • High incidences:S outheast Asia
  • HongKong and Singapore Chinese
  • ---Incidence Rate:30-50/100,000

6. Evident geographic distribution difference

  • Outside of endemic areas:
  • ---Incidence Rate: < 1 / 100,000
  • Lowest incidences
  • are seen in north American Caucasians andEuropeans,
  • Japanese and Indians.
  • Rare in Caucasians (white people)

7.

  • Intermediate incidence
  • -- EmigrantSouthernChineseinUSA,
  • -- Malaysia,
  • -- Singapore Malays
  • -- and the Eskimos in North America.
  • Intermediate incidence North Africa: The Arabs.
  • Incidence Rate: 5-10/100,000

Evident geographic distribution difference 8. ( ) 9. The High and Relatively High NPC Incidence Areas The Arctic Ocean Pacific Europe Asian Middle East Africa Oceania North America South America Latin America 10. Specific susceptible population

  • Mongolian
  • Chinese
  • Cantonese

11. Specific susceptible population North America Eskimos 12. NPC incidence rates between Chinese immigrantsand other racial residents in Los Angeles and Singapore 0.2 0.2 Vietnamese 0.5 0.5 Indian 2.0 6.5 Malayan 7.3 18.5 Chinese Singapore 0.3 0.2 Japanese 0.3 3.8 Philippine 2.8 9.8 Chinese 0.2 1.0 Ethiopian 0.2 0.5 CaucasianLos Angeles female maleincidencerates(/10 5 /year) countryrace 13. NPCincidence Rate of Chinese in Sigapore(/10 5 ) 4.7 14.1 FuJian 1.3 6.2 ShangHai 4.8 12.6 KeJia 6.2 18.3 ChaoZhou 11.0 29.1 Cantonese Incidence Rate of NPC MaleFemale language 14. Death Rates in different dialectal populations in GuangDong Province(10 5 ) 1.96 5.32 KeJia 2.89 6.18 ChaoZhou 4.32-5.84 12.08-15.96 Cantonese Death Rate of NPC MaleFemale language 15. Family cluster phenomenon

  • Family history of cancer:21.6%
  • Family history of NPC:12.3%
  • Statistics in GuangDong province

16.

  • 27% ofNPC patients
  • in Greenland were found to have a family history of cancer among first-degree relatives

Family cluster phenomenon 17. FamousFamily maleNPC Breast Cancer femaleNPC Male Liver Cancer 34.2%cancers 26.3% NPC 18. 4 Stable Incidence Rate andMen to Women Ratio: 2 ~ 3.8 :1 Changes of Cancer Incidence Rateduring 30 Years 19. 5Differences Between High andLow Incidence Areas Two frequency age peaks: 16-19 and50-59Quickly increase after the age of 30, and reaches thepeak between 50-59 Ageof disease onset The Low Incidence Areas The High Incidence Areas 20. 5 Pathologydifferences between high andlow incidence areas Type I:Well-differentiated squamous carcinoma Type II:DifferentiatedNon-keratinising Carcinoma Type III:Undifferentiated Non-keratinising Carcinoma WHO histological classification of nasopharyngeal carcinoma Type I Type II Type III 21. 5Differences Between High andLow Incidence Areas Type II and III Type II and III The Low Incidence Areas The High Incidence Areas Well-differentiated squamous carcinoma accounts for 25%Type I Well-differentiated squamous carcinoma accounts for 1.67% Type I Pathology Type 22. Aetiology NPC Lung Cancer ExternalFactors Internal Factors Internal Factors ExternalFactors 23. Aetiology NPC EB-Virus HereditaryFactors Environmental Factors 24. Hereditary susceptibility

  • Loss of Tumor Suppressor Genes
  • like: 3p13-3p25; 7p32-qter; and 9p21-22.
  • Human Leucocyte Antigen (HLA) and
  • its cytochrome p4502E
  • are possibly NPC susceptibility genes.
  • NPC susceptibility genes are possibly located
  • in : 4p1511-q12 area.(2002, nature)

25. EBV---Epstein Barr Virus

  • a DNA virus;
  • a member of the herpes sub-family
  • Infection of EBV is ubiquitous
  • In our country, EBV Infection occurs early
  • in life:90% of population have been
  • infected by this virus in the age of 3-5.
  • EBV can stay in the body life-long

26. EBV---Epstein Barr Virus

  • Antibodies IgA titres to EBV Antigens:
  • Viral Capsid Antigen ( VCA )
  • Early Antigen ( EA )
  • Usually VCA-IgA and EA-IgA positive rate and its
  • titres are much higher in NPC patients than in healthy
  • people and other cancer patients
  • Serve as a diagnostic marker.
  • Help doctors to identify NPC patients and to do early
  • diagnosis

27. EnvironmentalFactors Nitrosamines salted fish laboratory mice cancer of nasal cavity cancer of nasopharynx Cantonese-style salted fish and other preserved foods 28. EnvironmentalFactors

  • Extensive exposure to smoke and dust
  • (aromatic hydrocarbon)
  • 3,4- (3,4-benzpyrene)
  • 3,4-
  • 16.83 g

29. (nickel sulfate) DNP( EvironmentalFactors (microelements) ( nickel) EB , (selenium) (calcium) 30. .Anatomy of Nasopharynx 31. Soft palate the torus sphenoid sinusclivus atlasaxis Pharyngealtonsil 32. .Anatomy of Nasopharynx lateral pharyngealRecess(fossa ofRosenmullar) the torus ( Eustachian tube ( ) nasal septumChoanae ( ) 33. lateral pharyngeal recess (Fossa of Rosenmullar) the torus Soft palate 34. * Ascending palatine Ascending pharyngeal -main External carotid A MaxillarySupplying vessels 35. Maxillary 36. jugulodigastric Rouvieres lymph nodes,Deep cervical lymph nodes, Supraclavicular lymph nodes Lymphatic Drainage Necknodes 37. Clinical presentations

  • NeckSymptoms
  • Nasal Symptoms
  • Ear Symptoms
  • Neurological Symptoms
  • Cranial Nerve Paralysis
  • Headaches

38. Symptoms 1

  • NeckSymptoms:Lump in the neck 60-80%

39. jugulodigastric ( ) 40. Symptoms 2

  • Nasal symptoms
  • --Blood-stained nasal discharge (sputum ) :70%
  • (tumor friction with soft palate)
  • --Frequent nose bleeds (Epistaxis):37%
  • (when blood vessels broken)
  • --Nasal obstruction or stuffiness: 50%
  • ( Is a late finding indicating that a large tumor obstructing the posterior choanae)

41. Symptoms 3

  • Ear Symptoms:
  • -- Ringing in an ear (tinnitus ) :60%
  • -- Trouble hearing or hearing loss: 50%
  • -- Sense of fullness or pain in the ear :
  • (when tumor presses on or obstructseustachian tube )

42. Symptoms 4

  • Neurological Symptoms
  • Cranial Nerve Paralysis: 45%
  • VI and V cranial nerves are the most
  • commonly affected.
  • Headaches: 57-68%
  • due to skull base erosion or cranial nerve
  • irritation without bony involvement.

43. Cranial Nerves

  • 1. Olfactory7.Facial
  • 2. Optic8.Vestibulocochlear
  • 3. Oculomotor 9.Glossopharyngeal
  • 4. Trochlear10.Vagus
  • 5. Trigeminal 11.Spinal Accessory
  • 6. Abducens 12.Hypoglossal
  • : cervical sympathetic nerve

44. Cranial Nerve Damage

  • ( )
  • Damaged area is in or under the exit of cranial nerves
  • through bony base of skull
  • : Unilateral
  • V,VI :
  • cranial nervesV and VI are the most common affected nerves.

45. Exit of cranial nerves through bony base of skull Middle cranial fossa Posterior cranial fossa 46. Exit of cranial nerves through bony base of skull Optic foramen:II Cribriform plate:I Superior orbital fissure:III, IV, V 1 , VI 47. Exit of cranial nerves through bony base of skull Hypoglossal canal:XII Foramen rotundum: V 2 Foramen ovale:V 3 Internal auditory meatus:VII, VIII Jugular foramen:IX, X, XI 48. Optic foramen :II Superior orbital fissure :III, IV, V 1 VI Foramen rotundum :V 2 Foramen ovale :V 3 (Middle cranial fossa ) Internal auditory meatus :VII, VIII Jugular foramen :IX, X, XI Hypoglossal canal :XII (Posterior cranial fossa ) Exit of cranial nerves through bony base of skull 49. Cranial nerves III-VI are affected within theCavernous sinus III IV V 1 VIV 2 (Situated beside sella turcica) 50. Cavernous sinus (Situated beside sella turcica) 51. Cavernous sinus 52. ParapharyngealSpace Processus styloideus 53. Processus styloideus 54. Parapharyngeal Space 55. Parapharyngeal Space involvement 56. Nerves IX-XII are primarily affected in the Parapharyngeal Space below the skull base

  • 9.Glossopharyngeal
  • 10.Vagus
  • 11.Spinal Accessory
  • 12.Hypoglossal
  • : cervical sympathetic nerve

57. Symptoms of commonly affected cranial nerves

  • 3.Oculomotor:
  • (midbrain) ( ) ( )
  • ptosis) .
  • (mydriasis)
  • (failure of accommodation)

58. Unilateralptosis oculomotor nerveparalysis 59.

  • 5.Trigeminal:
  • (motor) V 3
  • (pons) (masticatory muscles)
  • (jaw tilt)
  • Difficulty opening the mouth(trismus)

Symptoms of commonly affected cranial nerves 60.

  • 5.Trigeminal:
  • (sensory)
  • 2/3
  • ,
  • Numbness in the face or facial paresthesia
  • disappearance of corneal reflex

Symptoms of commonly affected cranial nerves 61. V1 V2 V3 62. (jaw tilt) ptosis) CN III V VI (+) 63.

  • 6. VI:
  • ( ) ( )
  • ( ) lateral rectus muscle
  • failure of abduction), double vision: diplopia

Symptoms of commonly affected cranial nerves 64. 65. CN VI XII + Horner s + tongue lateralized toaffected side upon protrusion failure of abduction 66.

  • 9.Glossopharyngeal :
  • (medulla oblongata) ( )
  • * (soft palate depression)
  • * 1/3 (deficiency of taste sensation ofposterior third of the tongue)
  • * (dysphagia)

Symptoms of commonly affected cranial nerves 67.

  • 10.vagus:
  • ( )
  • * aspiration
  • * hoarseness

Symptoms of commonly affected cranial nerves 68.

  • 12.Hypoglossal:
  • ( )
  • * (tongue lateralized to affected side upon protrusion) (tongue atrophy)

Symptoms of commonly affected cranial nerves 69. N 70. DiagnosisCTscan endoscopy laboratory 71. Procedure of diagnosis

  • Take a complete medical history
  • Noting all symptoms and risk factors.
  • Clinical examination of NP:
  • Indirect mirror examinationor
  • direct fibroscopic examination
  • Clinical examination of neck mass
  • EBV Serology :VCA-IgA; EA-IgA; EBV-DNaseAb
  • Imaging : CT or MRI of NP and neck
  • Pathology: - biopsy

72. Indirect mirror examination 73. With a forcep Rarely used Inconvenient 74. Direct transnasal endoscopic examination Widelyused 75. Anatomic Types NodularFungatingSubmucosalInverting UlceratingMixed 76. Imaging Study

  • Help to make the correct diagnosis
  • Help To know the disease stage
  • Help to determine the target volume of
  • radiotherapy
  • Help to evaluate the treatment results
  • Follow-up

77. Imaging Study 78. Imaging Study 79. Imaging Study 80. Imaging Study 81. MRI of NP---- better than CT 82. MRI of NP---- better than CT MRI is more sensitive thanCT in detecting tumors of the nasopharynx and its possible spread to nearby tissues or lymph nodes. 83. More examination To find Metastasis

  • Chest x-ray:
  • to identify lung metastasis
  • Abdominal ultrasound:
  • to find liver metastasis.
  • ECT of bones: Radionuclide bone scan
  • Using very small amounts of radioactive
  • material to determine whether the cancer
  • has spread to the bones.

84. PET(positron emission tomography)

  • This test creates an image of the body using an injection of a substance, such as glucose (sugar), in a low dose, radioactive form.
  • Since it is new, the benefit of PET scanning is not clearly proven, but some doctors may recommend it to look for cancers that cannot be identified by other scans or tests.

85. PET/CT 86. PET/CT 87. PET/CT 88. Pathological study

  • The diagnosis can be made only after the
  • biopsy of the nasopharyngeal tumor
  • Neck nodes biopsy isdone only when the
  • biopsy of the nasopharyngeal tumor is
  • impossible

89. Clinical Types of NPC Ascending Type -----Type of Cranial Nerves damage Descending Type -----Type of Lymphatic Metastasis MixedType Metastasis Type: 90. Ascending Type(Type of Cranial Nerves) Damages ofII III IV V cranial Nervesand/or skull baseBut No lymph node Metastasis 91. Descending Type (Type of Lymphatic Metastasis)

  • Very large lymph node
  • Metastasis
  • Withoutinvolvement of
  • cranial Nervesand/or
  • base of skull

92. MixedType

  • lymph node Metastasis
  • +damage ofcranial Nervesand/or cranial base

93. Metastasis Type: 1.Bone 2.Liver 3.Lung 4.Other: abdominal nodes 94. Metastasis of NPC

  • Bone is the most commonly affected area
  • ( pelvis vertebral column; ribs; extremities)
  • Liver is the second most common affected area
  • Lung is the another common affected area

95. PET/CT: dorsal vertebra lumbar vertebra 96. 97. Lung metastasis Liver metastasis 98. Differentiated diagnosis

  • Hyperplasia of adenoids
  • Tuberculosis
  • Median Necrotic Granuloma (NK/T lymphoma)
  • Fibroangioma
  • Chronic inflammation
  • Chordoma;craniopharyngioma
  • Cerviccal lymphadenitis

99. Differential Diagnosis Adenoids 100. Differential Diagnosis Median Necrotic Granuloma tuberculosis 101. Fibroangioma 102. Clinical staging

  • Make treatment strategy
  • Predictprognosis
  • TNM Staging System
  • (T, tumor)
  • How large is the primary tumor
  • (N, node)
  • Has the tumor spread to the lymph nodes?
  • (M, metastasis)
  • Has the cancer spread to other parts of the body?

103. NPC 92 Clinical Classification 104. T staging

  • T1: tumor limited to the nasopharynx.
  • T2: tumor involving nasal cavity, oropharynx, soft
  • palate, and parapharyngeal space. Extension
  • before SO-line
  • T3: tumor extension overSO-line , involving either anterior
  • or posterior cranial nerves, base of skull
  • pterygoprocesse zone, pterygopalatine fossa.
  • T4: tumor involving both anterior and posterior
  • cranial nerves, paranasal sinus, cavernous sinus,
  • orbit, infratemporal fossa, and direct invasion of
  • first and second cervical vertebrae

105. N - MStaging

  • N1: Upper neck nodes < 4cm, mobile
  • N2: Lower neck nodes or nodes 4~7cm;
  • N3: Node >7cm or supraclavicular node,or
  • fixed node

M0: no metastasis M1: metastasis 106. Treatment Option Radiotherapy:Radical Chemotherapy:Adjuvant Operation:Complementary 107. Treatmentprotocol -- stratifiedtherapy Radiotherapy Induction or Concomitant Adjuvant chemotherapy Radiotherapy Induction or Adjuvant chemotherapy N2-3 Radiotherapy Induction or Concomitant chemotherapy RadiotherapyN0-1 T3-4 T1-2 108. Brachytherapyis most often used to manage cancers that have recurred (come back) after treatment. It may also be used to treat the small original tumor. Intensity Modulated Radiation Therapy (IMRT) A new method of external radiation, known for delivering more effective doses of radiation while reducing the damage to healthy cells, thus causing fewer side effects. Stereotactic radiosurgerydelivers radiation therapy precisely to the tumor using a machine called agamma knife . This can be used to treat tumors that have invaded the base of the skull, or tumors that have recurred at the base of the brain or skull. 109. 80 110. 90 LN (Ia) 111. 112. Radiotherapy:Radical 113. 90 114. From Bucci, M. K. et al.CA Cancer J Clin 2005;55:117-134. 21 115. IMRT 116. IMRT 117. External beam radiation - complications

  • xerostomia, tooth decay
  • Endocrine disorders hypopituitarism hypothyroidism, hypothalamic disfunction
  • Soft tissue fibrosis including trismus
  • Ophthalmologic problems
  • Skull base necrosis
  • Hearing loss
  • temporal lobe necrosis;peripheral nerve damages(nerve atrophy).

118. Chemotherapy: combined

  • : Neo-adjuvant chemotherapy
  • recommended
  • : Adjuvant chemotherapy
  • Selected patients
  • :
  • Concomitant Chemoradiotherapy
  • Standard

119. Protocols of chemotherapy

  • PF: DDP+5-Futhe first line
  • PFB: DDP+5-FU+BLM
  • PT: Paclitaxol + DDP
  • GP: Gemcitabine + DDP
  • Taxotere + DDP

120. 5-year survival of 351 cases aftercombined stratified therapy (92classification) 22% 50% 76% 90% Radiotherapy only (411 cases) 40.2% 62.3% 80% 95% Combined Therapy (351 cases) IVa III II I stage 121. Surgery-- for selected patients

  • NP Residual disease
  • NP Recurrent disease
  • (when radiation therapy is contraindicated)
  • Residual cervical nodes
  • Recurrent cervical nodes

122. 123. thanks for your attention !